Ark Genomic Revolution UCITS ETF (LON:ARCG)
742.35
+22.40 (3.11%)
Last updated: Sep 22, 2026, 4:29 PM GMT
LON:ARCG Holdings Information
LON:ARCG is an equity ETF with a total of 32 individual holdings. The top holdings are Twist Bioscience stock at 10.00%, Tempus AI at 9.25%, 10x Genomics at 7.40%, CRISPR Therapeutics AG at 5.39%, and Absci at 4.84%.
Total Holdings
32
Top 10 Percentage
59.14%
Asset Class
Equity
ETF Category
Theme
Assets
81.92M
PE Ratio
n/a
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TWST | Twist Bioscience Corporation | 10.00% |
| 2 | TEM | Tempus AI, Inc. | 9.25% |
| 3 | TXG | 10x Genomics, Inc. | 7.40% |
| 4 | CRSP | CRISPR Therapeutics AG | 5.39% |
| 5 | ABSI | Absci Corporation | 4.84% |
| 6 | NTRA | Natera, Inc. | 4.62% |
| 7 | CDNA | CareDx, Inc. | 4.60% |
| 8 | ILMN | Illumina, Inc. | 4.54% |
| 9 | PSNL | Personalis, Inc. | 4.53% |
| 10 | LLY | Eli Lilly and Company | 3.96% |
| 11 | CMPS | COMPASS Pathways plc | 3.67% |
| 12 | GH | Guardant Health, Inc. | 3.26% |
| 13 | BEAM | Beam Therapeutics Inc. | 2.90% |
| 14 | SDGR | Schrödinger, Inc. | 2.81% |
| 15 | NTLA | Intellia Therapeutics, Inc. | 2.76% |
| 16 | RXRX | Recursion Pharmaceuticals, Inc. | 2.69% |
| 17 | WGS | GeneDx Holdings Corp. | 2.54% |
| 18 | NRIX | Nurix Therapeutics, Inc. | 2.37% |
| 19 | ARCT | Arcturus Therapeutics Holdings Inc. | 2.10% |
| 20 | BFLY | Butterfly Network, Inc. | 2.08% |
| 21 | ADPT | Adaptive Biotechnologies Corporation | 2.04% |
| 22 | VCYT | Veracyte, Inc. | 1.84% |
| 23 | ALMR | Alamar Biosciences, Inc. | 1.74% |
| 24 | IONS | Ionis Pharmaceuticals, Inc. | 1.37% |
| 25 | GENB | Generate Biomedicines, Inc. | 1.24% |
As of Sep 18, 2026